Advertisement
Screener

DANAHER CORPORATION (DHR) Spending and interest coverage

DANAHER CORPORATION (DHR) Spending and interest coverage

  • R&D / revenue · 12 months: Value 6.43%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-26..
  • Stock-based compensation / revenue · 12 months: Value 1.18%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-26..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-26; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months6.43%Research and development expense / revenue. Period ending 2026-06-26.

$1.61B ÷ $25.11B × 100 ≈ 6.43%

Stock-based compensation / revenue · 12 months1.18%Share-based compensation / revenue. Period ending 2026-06-26.

$297.00M ÷ $25.11B × 100 ≈ 1.18%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending1.61B USDResearch and Development Expense
Revenue25.11B USDRevenue from Contract with Customer, Excluding Assessed Tax
Stock-based compensation297.00M USDShare-based Payment Arrangement, Noncash Expense
Operating income5.13B USDOperating Income (Loss)
Interest expense · reported / estimated(m)Interest Expense · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-26$1.61B$25.11B$297.00M$5.13B(m)6.43%1.18%(m)(m)
2026-03-27$1.61B$24.78B$295.00M$4.76B(m)6.48%1.19%(m)(m)
2025-12-31$1.60B$24.57B$298.00M$4.69B(m)6.50%1.21%(m)(m)
2025-09-26$1.60B$24.27B$292.00M$4.61B(m)6.60%1.20%(m)(m)
2025-06-27$1.61B$24.01B$293.00M$4.42B(m)6.69%1.22%(m)(m)
2025-03-28$1.59B$23.82B$289.00M$4.83B(m)6.70%1.21%(m)(m)
2024-12-31$1.58B$23.88B$288.00M$4.86B(m)6.63%1.21%(m)(m)
2024-09-27$1.55B$23.74B$292.00M$4.78B(m)6.52%1.23%(m)(m)
2024-06-28$1.53B$23.57B$287.00M$5.00B(m)6.48%1.22%(m)(m)
2024-03-29$1.50B$23.74B$296.00M$5.00B$285.00M6.31%1.25%17.53×Reported
2023-12-31$1.50B$23.89B$306.00M$5.20B$286.00M6.29%1.28%18.19×Reported
2023-09-29$1.72B$29.57B$346.00M$6.96B$272.00M5.81%1.17%25.58×Reported
2023-06-30$1.72B$30.36B$343.00M$7.53B$241.00M5.67%1.13%31.26×Reported
2023-03-31$1.73B$30.95B$335.00M$8.31B$225.00M5.60%1.08%36.93×Reported
2022-12-31$1.75B$31.47B$336.00M$8.69B$211.00M5.54%1.07%41.18×Reported
2022-09-30$1.79B$31.25B$329.00M$8.55B$203.00M5.72%1.05%42.10×Reported
2022-07-01$1.81B$30.82B$292.00M$7.84B$223.00M5.87%0.95%35.16×Reported
2022-04-01$1.80B$30.28B$244.00M$7.64B$234.00M5.95%0.81%32.65×Reported
2021-12-31$1.74B$29.45B$218.00M$7.46B$238.00M5.91%0.74%31.37×Reported
2021-10-01$1.64B$28.07B$209.00M$6.91B$254.00M5.85%0.74%27.21×Reported
2021-07-02$1.54B$26.72B$202.00M$6.69B$270.00M5.78%0.76%24.78×Reported
2021-04-02$1.44B$24.80B$196.00M$5.53B$286.00M5.81%0.79%19.34×Reported
2020-12-31$1.35B$22.28B$187.00M$4.23B$275.00M6.05%0.84%15.39×Reported
2020-10-02$1.25B$20.39B$178.40M$3.59B$247.10M6.11%0.87%14.53×Reported
2020-07-03$1.19B$18.89B$174.10M$3.28B$194.40M6.28%0.92%16.87×Reported
2020-04-03$1.15B$18.03B$168.90M$3.25B$135.50M6.35%0.94%23.96×Reported
2019-12-31$1.13B$17.91B$158.80M$3.27B$108.60M6.29%0.89%30.10×Reported
2019-09-27$1.27B$20.44B$169.80M$3.40B$104.00M6.22%0.83%32.74×Reported
2019-06-28$1.25B$20.25B$163.40M$3.40B$119.00M6.19%0.81%28.58×Reported
2019-03-29$1.24B$20.08B$157.30M$3.38B$141.60M6.19%0.78%23.90×Reported
2018-12-31$1.23B$19.89B$151.40M$3.40B$157.40M6.19%0.76%21.63×Reported
2018-09-28$1.21B$19.62B$146.20M$3.41B$165.40M6.17%0.75%20.61×Reported
2018-06-29$1.19B$19.29B$141.40M$3.34B$164.00M6.16%0.73%20.35×Reported
2018-03-30$1.16B$18.82B$139.10M$3.15B$161.50M6.16%0.74%19.49×Reported
2017-12-31$1.13B$18.33B$139.40M$3.02B$162.70M6.16%0.76%18.57×Reported
2017-09-29$1.10B$17.83B$138.30M$2.80B$153.20M6.16%0.78%18.30×Reported
2017-06-30$1.06B$17.43B$136.30M$2.74B$157.00M6.08%0.78%17.42×Reported
2017-03-31$1.02B$17.16B$133.80M$2.76B$171.80M5.92%0.78%16.08×Reported
2016-12-31$975.10M$16.88B$129.80M$2.75B$184.40M5.78%0.77%14.92×Reported
2016-09-30$1.32B$22.75B$158.40M$3.98B$225.80M5.81%0.70%17.63×Reported
2016-07-01$1.29B$22.08B$167.80M$3.70B$232.60M5.85%0.76%15.89×Reported
2016-04-01$1.26B$21.26B$149.80M$3.60B$195.20M5.93%0.70%18.42×Reported
2015-12-31$1.24B$20.56B$139.00M$3.47B$162.80M6.03%0.68%21.31×Reported
2015-10-02$1.37B$20.66B$139.30M$3.44B$133.00M6.63%0.67%25.88×Reported
2015-07-03$1.35B$20.29B$126.90M$3.46B$117.00M6.65%0.63%29.56×Reported
2015-04-03$1.34B$20.12B$123.50M$3.42B$120.40M6.66%0.61%28.38×Reported
2014-12-31$1.31B$19.91B$121.10M$3.43B$122.70M6.60%0.61%27.96×Reported
2014-09-26$1.31B$19.76B$120.90M$3.43B$128.50M6.63%0.61%26.71×Reported
2014-06-27$1.29B$19.56B$116.60M$3.38B$133.00M6.60%0.60%25.40×Reported
2014-03-28$1.27B$19.34B$118.90M$3.33B$139.20M6.55%0.61%23.94×Reported
2013-12-31$1.25B$19.12B$117.70M$3.27B$145.90M6.54%0.62%22.45×Reported
2013-09-27$1.21B$18.83B$116.20M$3.25B$154.40M6.44%0.62%21.05×Reported
2013-06-28$1.19B$18.57B$115.60M$3.19B$158.80M6.42%0.62%20.11×Reported
2013-03-29$1.16B$18.39B$114.00M$3.16B$157.30M6.33%0.62%20.10×Reported
2012-12-31$1.14B$18.26B$109.90M$3.17B$157.50M6.23%0.60%20.10×Reported
2012-09-28$1.13B$18.00B$103.41M$3.08B$154.08M6.25%0.57%20.00×Reported
2012-06-29$1.12B$18.03B$100.05M$2.97B$157.09M6.23%0.55%18.90×Reported
2012-03-30$1.07B$17.11B$96.51M$2.77B$150.62M6.27%0.56%18.37×Reported
2011-12-31$1.02B$16.09B$95.60M$2.62B$141.64M6.33%0.59%18.48×Reported
2011-09-30$957.83M$15.08B$93.78M$2.48B$133.25M6.35%0.62%18.59×Reported
2011-07-01$864.66M$13.66B$93.21M$2.37B$121.74M6.33%0.68%19.50×Reported
2011-04-01$820.06M(m)$94.42M(m)$118.97M(m)(m)(m)Reported
2010-12-31$809.48M$13.20B$88.12M$2.17B$120.78M6.13%0.67%17.94×Reported
2010-10-01$741.69M$12.73B$86.38M$1.93B$127.56M5.83%0.68%15.16×Reported
2010-07-02$698.14M$12.29B$82.54M$1.83B$127.50M5.68%0.67%14.32×Reported
2010-04-02$658.99M$11.65B$79.90M$1.64B$129.27M5.66%0.69%12.65×Reported
2009-12-31$632.65M$11.18B$87.35M$1.54B$122.66M5.66%0.78%12.58×Reported
2009-10-02(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-07-03(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-04-03(m)(m)(m)(m)(m)(m)(m)(m)(m)
2008-12-31$725.44M$12.70B$86.00M$1.87B$130.17M5.71%0.68%14.36×Reported
2008-09-26(m)(m)(m)(m)(m)(m)(m)(m)(m)
2008-06-27(m)(m)(m)(m)(m)(m)(m)(m)(m)
2007-12-31$601.42M$11.03B$73.35M$1.74B$109.70M5.45%0.67%15.87×Reported

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Keysight Technologies, Inc. (KEYS)United States$60.876B51.86
AMETEK INC/ (AME)United States$56.772B35.17
ROPER TECHNOLOGIES INC (ROP)United States$36.012B13.63
MKS INC (MKSI)United States$17.440B68.37
Fortive Corp (FTV)United States$16.897B31.51
COGNEX CORP (CGNX)United States$9.711B65.26
Ralliant Corp (RAL)United States$7.737B-6.14
Sensata Technologies Holding plc (ST)$5.976B77.15
MESA LABORATORIES INC /CO/ (MLAB)United States$0.768B116.22
Senseonics Holdings, Inc. (SENS)United States$0.546B-2.74